Alzheimer’s disease (AD) |
Intravenous (IV) |
AMP-activated protein kinase (AMPK) |
Amyloid precursor protein (APP) |
Amyloid-beta (Aβ) |
Analysis of Variance (ANOVA) |
Citrate synthase (CS) |
Cytochrome c oxidase (COX) |
Discosoma sp. red fluorescent protein (DsRed) |
Familial Alzheimer’s disease (FAD) |
Five FAD mutations (5XFAD mice) |
Fluoro-Jade C (FJC) |
Gamma-Aminobutyric Acid (GABA) |
Gene Ontology enRIchment anaLysis analysis and visuaLizAtion tool (GOrilla) |
Gene Ontology Term Enrichment (GOTERM) |
Histone deacetylase (HDAC) |
In vivo imaging system (IVIS) |
Insulin-like growth factor-binding protein (Igfbp) |
Intracerebroventricular (ICV) |
Kyoto Encyclopedia of Genes and Genomes (KEGG) |
Label-free quantitation (LFQ) |
Least significant difference (LSD) |
Liquid chromatography-tandem mass spectrometry (LC-MSMS) |
Neuronal nuclei (NeuN) |
Partial least square discriminant analysis (PLS-DA) |
Peroxisome proliferator-activated receptor (PPAR) |
Phosphoinositide 3-kinase (PI3K) |
Post-synaptic density (PSD) |
Post-translational modification (PTM) |
Presenilin1 (PS1) |
Red fluorescent protein (RFP) |
The Small Molecule Pathway Database (SMPDB) |
Transgenic (Tg) |
Vascular endothelial growth factor (VEGF) |
VIP (measure of a variable’s importance) |
Full names of proteins are presented in the Supplemental-proteomics-excels |